NanoViricides, Inc. (NNVC)

NanoViricides Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Selling, General & Admin	2.63	2.55	2.33	2.63	3.3	2.74
Research & Development	7.17	6.39	5.78	6.11	4.7	5.92
Operating Expenses	9.8	8.94	8.11	8.74	8	8.66
Operating Income	-9.8	-8.94	-8.11	-8.74	-8	-8.66
Interest Expense / Income	0.05	0	0.01	0.09	0.09	0
Other Expense / Income	-0.34	-0.36	-0.01	-0.01	5.36	-0.24
Pretax Income	-9.51	-8.59	-8.11	-8.82	-13.45	-8.42
Net Income	-9.51	-8.59	-8.11	-8.82	-13.45	-8.42
Shares Outstanding (Basic)	12	12	12	11	6	4
Shares Outstanding (Diluted)	12	12	12	11	6	4
Shares Change	1.23%	0.79%	5.81%	94.08%	56.45%	10.60%
EPS (Basic)	-0.82	-0.74	-0.70	-0.81	-2.39	-2.35
EPS (Diluted)	-0.82	-0.74	-0.70	-0.81	-2.39	-2.35
Free Cash Flow	-6.39	-5.82	-6.22	-8.45	-6.67	-6.88
Free Cash Flow Per Share	-0.54	-0.50	-0.54	-0.78	-1.19	-1.92
EBITDA	-8.7	-7.84	-7.38	-8.03	-12.65	-7.73
Depreciation & Amortization	0.76	0.75	0.72	0.7	0.7	0.7
EBIT	-9.46	-8.59	-8.1	-8.74	-13.35	-8.42

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).